Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2005
09/22/2005CA2555867A1 Arylalkylamino-substituted quinazoline analogues
09/21/2005EP1577304A1 Production method of aminopyrimidine compound
09/21/2005EP1577303A1 5-protected aminopyrimidine compound, production method thereof and intermediate thereof
09/21/2005EP1577286A1 Perfluoroallyloxy compound and liquid-crystal composition containing the compound
09/21/2005EP1575949A1 Fungicides
09/21/2005EP1575940A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575506A2 Methods for improvement of lung function using tgf-beta inhibitors
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/20/2005US6946688 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
09/20/2005US6946555 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
09/20/2005US6946469 Viricides
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/15/2005WO2005085387A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085213A1 Compounds derived from 4­-anilinequinazolines with adenosine-kiase inhibitor properties
09/15/2005WO2005085212A1 Substituted pyrimidine derivative
09/15/2005WO2005085211A1 Use of pyrimidine compounds in the preparation of parasiticides
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085181A1 Functional material comprising fluorine compound
09/15/2005WO2005065416A3 Process for the preparation of pyridopyrimidones
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2005007672A3 Small molecule toll-like receptor (tlr) antagonists
09/15/2005WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203114 Pyrimidine-indole derivatives; cancer, autoimmunological, metabolic, inflammatory, infection (bacterial, viral, yeast, fungal, etc.), diseases of the central nervous system, degenerative neural disease, allergy/asthma, dermatology, angiogenesis, neovascularization, vasculogenesis, and cardiovascular
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203092 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
09/15/2005US20050202973 Aryl-alkyne compounds as herbicides
09/15/2005US20050201955 Use of compatible solutes for inhibiting the release of ceramides
09/15/2005US20050199856 Compound, liquid-crystal composition and optical material
09/15/2005US20050198748 Water-soluble fiber-reactive dyes, method for the production and use thereof
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/15/2005CA2558109A1 Heteroaryl-fused pyrazolo derivatives
09/15/2005CA2557749A1 Use of pyrimidine compounds in the preparation of parasiticides
09/15/2005CA2556386A1 Isothiourea derivatives
09/14/2005EP1574502A1 Use of pyrimidine compounds in the preparation of parasiticides
09/14/2005EP1572667A1 Cathepsin cysteine protease inhibitors and their use
09/14/2005EP1572666A1 3h-quinazolin-4-one derivatives
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572249A1 Solid-phase fluorination of uracil and cytosine
09/14/2005EP1572210A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission
09/14/2005CN1668302A Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
09/14/2005CN1668299A Methods for using JNK inhibitors for treating or preventing disease-related wasting
09/14/2005CN1666983A Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/13/2005US6943253 6-phenylpyrrolopyrimidinedione derivatives
09/13/2005US6943252 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
09/13/2005US6943159 amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor agonists or antagonists such as 3-Cyclohexyl-7-(1-hydroxyethyl)-1,2,3,4-tetrahydro-1,2,4-benzothiadiazine-1,1-dioxide, used for prophylaxis of nervous system disoders
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
09/09/2005WO2005082863A2 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197354 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS
09/08/2005US20050197351 Such as 4-{N-[4-(4-methylbenzenesulfonylamido)benzyl]acetamido}-3-phenyl-2-(piperidine-1-yl)-3,4-dihydroquinazoline; for therapy of angina pectoris, high blood pressure, myocardial disease, pain and epilepsy by blocking the T-type calcium channel
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569916A1 Substituted aralkyl derivatives
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569914A1 Pyrimidine-sulfamides and their use as endothelian receptor antagonist
09/07/2005EP1569913A1 Compositions containing pyrimidine derivatives as inhibitors of cox-2
09/07/2005EP1569658A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
09/07/2005EP1569652A2 N sp 4 /sp-acylcytosine nucleosides for treatment of viral iinfections
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1458717B1 Aroyl pyridinones
09/07/2005EP1095028B1 Substituted acylamino phenyl uracils
09/07/2005CN1665904A Luminescent compositions
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665788A Pyrimidinone compounds, compositions and methods